CD28 and cancer: DMSNs3@HA is a DC-like nanoparticle modified with hyaluronic acid to target CD44 overexpressed on cancer cells, and conjugated with anti-CD3, anti-CD28 to interact with T cell, and anti-PD-1 to block the PD-1/PD-L1 pathway.